Skip to main navigation
logo
  • About
    • Company
    • Leadership
    • Laboratory
    • Careers
  • Products
    • Immuno-Oncology
    • Oncology Diagnostics
    • Pharma Research Solutions
  • Applications
    • Biomarker Discovery
    • Personalized Therapeutics
  • Technology
    • Our Processes
    • Unlock the power of DNA
    • Optimizing RNA
    • NeoantigenID
    • MHC binding prediction
    • ImmunogenomicsID
    • Reliable delivery
  • Resources
    • What’s New
    • Conferences
    • Library
    • Blog
    • Contact
  • Investors
    • Overview
    • Press Releases
    • Events
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
    • Investor Contacts
    • Email Alerts

Press Releases

Press Releases

Apr 08, 2021
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
Mar 29, 2021
Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development
Mar 08, 2021
Personalis Announces Changes to its Board of Directors
Feb 25, 2021
Personalis Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 17, 2021
Natera and Personalis Partner for Personalized Monitoring in Oncology
Feb 16, 2021
Personalis to Present at Upcoming Investor Conferences
Feb 11, 2021
Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021
Feb 08, 2021
Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer
Feb 04, 2021
Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Jan 26, 2021
Personalis Announces Pricing of Public Offering of Common Stock

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 12
Print Page
RSS Feeds
Email Alerts
Contact IR
Corporate Website
© 2021 Personalis Inc. All rights reserved.
logo